These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29206826)

  • 1. [Response to serotonergic and noradrenergic antidepressants: a crossover study of fluoxetine and desipramine in patients with first major depression episode].
    Ontiveros-Sánchez de la Barquera JA
    Gac Med Mex; 2017; 153(6):688-694. PubMed ID: 29206826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SSRIs drug Fluoxetine, but not the noradrenergic tricyclic drug Desipramine, improves memory performance during acute major depression.
    Levkovitz Y; Caftori R; Avital A; Richter-Levin G
    Brain Res Bull; 2002 Aug; 58(4):345-50. PubMed ID: 12183009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes and genome-wide association for a brain methylation site in an antidepressant pharmacogenetics study in Mexican Americans.
    Wong ML; Dong C; Flores DL; Ehrhart-Bornstein M; Bornstein S; Arcos-Burgos M; Licinio J
    Am J Psychiatry; 2014 Dec; 171(12):1297-309. PubMed ID: 25220861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind, randomized study.
    Nelson JC; Mazure CM; Jatlow PI; Bowers MB; Price LH
    Biol Psychiatry; 2004 Feb; 55(3):296-300. PubMed ID: 14744472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noradrenergic versus serotonergic antidepressants: predictors of treatment response.
    Schatzberg AF
    J Clin Psychiatry; 1998; 59 Suppl 14():15-8. PubMed ID: 9818626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action.
    Delgado PL; Miller HL; Salomon RM; Licinio J; Krystal JH; Moreno FA; Heninger GR; Charney DS
    Biol Psychiatry; 1999 Jul; 46(2):212-20. PubMed ID: 10418696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of noradrenergic and serotonergic antidepressants in chronic back pain: a preliminary concentration-controlled trial.
    Atkinson JH; Slater MA; Capparelli EV; Wallace MS; Zisook S; Abramson I; Matthews SC; Garfin SR
    J Clin Psychopharmacol; 2007 Apr; 27(2):135-42. PubMed ID: 17414235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analgesic effects of serotonergic, noradrenergic or dual reuptake inhibitors in the carrageenan test in rats: evidence for synergism between serotonergic and noradrenergic reuptake inhibition.
    Jones CK; Eastwood BJ; Need AB; Shannon HE
    Neuropharmacology; 2006 Dec; 51(7-8):1172-80. PubMed ID: 17045620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression.
    Musselman DL; Somerset WI; Guo Y; Manatunga AK; Porter M; Penna S; Lewison B; Goodkin R; Lawson K; Lawson D; Evans DL; Nemeroff CB
    J Clin Psychiatry; 2006 Feb; 67(2):288-96. PubMed ID: 16566626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation strategies with serotonergic-noradrenergic combinations.
    Nelson JC
    J Clin Psychiatry; 1998; 59 Suppl 5():65-8; discussion 69. PubMed ID: 9635550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind study of high-dose fluoxetine versus lithium or desipramine augmentation of fluoxetine in partial responders and nonresponders to fluoxetine.
    Fava M; Alpert J; Nierenberg A; Lagomasino I; Sonawalla S; Tedlow J; Worthington J; Baer L; Rosenbaum JF
    J Clin Psychopharmacol; 2002 Aug; 22(4):379-87. PubMed ID: 12172337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression.
    Miller HL; Delgado PL; Salomon RM; Berman R; Krystal JH; Heninger GR; Charney DS
    Arch Gen Psychiatry; 1996 Feb; 53(2):117-28. PubMed ID: 8629887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression.
    Nelson JC; Mazure CM; Bowers MB; Jatlow PI
    Arch Gen Psychiatry; 1991 Apr; 48(4):303-7. PubMed ID: 2009031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder.
    Barr LC; Goodman WK; Anand A; McDougle CJ; Price LH
    Am J Psychiatry; 1997 Sep; 154(9):1293-5. PubMed ID: 9286191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reboxetine, a new noradrenaline selective antidepressant, is at least as effective as fluoxetine in the treatment of depression.
    Andreoli V; Caillard V; Deo RS; Rybakowski JK; Versiani M
    J Clin Psychopharmacol; 2002 Aug; 22(4):393-9. PubMed ID: 12172339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind comparison of sertraline and fluoxetine in the treatment of major depressive episode in outpatients.
    Sechter D; Troy S; Paternetti S; Boyer P
    Eur Psychiatry; 1999 Mar; 14(1):41-8. PubMed ID: 10572324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 1: predictors of clinical response in fluoxetine-resistant depression.
    Papakostas GI; Petersen T; Mischoulon D; Ryan JL; Nierenberg AA; Bottiglieri T; Rosenbaum JF; Alpert JE; Fava M
    J Clin Psychiatry; 2004 Aug; 65(8):1090-5. PubMed ID: 15323594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In the rat forced swimming test, chronic but not subacute administration of dual 5-HT/NA antidepressant treatments may produce greater effects than selective drugs.
    Rénéric JP; Bouvard M; Stinus L
    Behav Brain Res; 2002 Nov; 136(2):521-32. PubMed ID: 12429415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suicidality scores during double-blind fluoxetine and desipramine treatment in Mexican Americans.
    Sharma A; Busnello JV; Ribeiro L; Thakur S; Whelan F; Elashoff RM; Wong ML; Licinio J
    J Clin Psychopharmacol; 2007 Feb; 27(1):99-101. PubMed ID: 17224728
    [No Abstract]   [Full Text] [Related]  

  • 20. Do depressed subjects who have failed both fluoxetine and a tricyclic antidepressant respond to the combination?
    Levitt AJ; Joffe RT; Kamil R; McIntyre R
    J Clin Psychiatry; 1999 Sep; 60(9):613-6. PubMed ID: 10520980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.